| Value | ₹503.1 Cr |
|---|
BSE filing, NSE: KPL. Summary written from the filing by ALFA Finder's alert engine.
Kwality Pharmaceuticals Ltd: key numbers
- Share price
- ₹3,689.25
- Market cap
- ₹3,828 Cr
- Revenue (annual)
- ₹503.1 Cr
- Net profit (annual)
- ₹67.35 Cr
- P/E (TTM)
- 47.2×Sector 46.1×
- Promoter holding
- 54.86%+0.00% QoQ
- FII holding
- 2.50%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Kwality Pharmaceuticals Ltd
All →Kwality Pharmaceuticals Other Announcement
Kwality Pharmaceuticals Ltd filed its shareholding pattern for the quarter ended September 30, 2026, as required by SEBI regulations.
Kwality Pharmaceuticals Capacity Expansion
Kwality Pharmaceuticals acquired 4 acres adjacent to its Amritsar plant to build a fully automated facility with 10+ production lines. Completion is targeted by Q4 FY2028 with full operations by Q2 FY2029.
- Execution
- Completion by Q4 FY2028; full operations by Q2 FY2029
- manufacturing production lines (injectable + oral solid + ophthalmic)
- 10 production lines
Kwality Pharmaceuticals Management Change
Kwality Pharmaceuticals has regularized the appointment of Mr. Swanith Kapoor as Independent Director and reappointed Mr. Aditya Arora as Whole Time Director for five years.
Kwality Pharmaceuticals Annual General Meeting
Kwality Pharmaceuticals Limited conducted its 43rd Annual General Meeting on August 31, 2026, via video conferencing. The meeting covered routine shareholder resolutions and director re-appointments.
Kwality Pharmaceuticals Earnings Call Transcript: Key Takeaways
Kwality Pharma Q1FY27 con-call highlights revision of FY27 revenue target to ₹700Cr+ with 26-27% EBITDA margins, driven by niche injectable registrations in LATAM and MENA regions.
- Call
- Guides 30% growth
Kwality Pharmaceuticals Investor Presentation: Key Takeaways
Kwality Pharma reported strong Q1FY27 performance with revenue up 45.7% YoY. Management raised FY27 revenue guidance to INR 700+ Cr and improved margin outlook.
- Call
- Guides 39% growth
Other financial results announcements
All →Vaibhav Global Q2 FY27 Results: Net Profit ₹41.7 Cr, Down 12.4% YoY
Vaibhav Global Ltd reported revenue from operations of ₹938.4 Cr (+7.0% YoY) and net profit of ₹41.7 Cr (-12.4% YoY) for Q2 FY27.
- Key figure
- Net profit ₹41.7 Cr · -12.4% YoY
MosChip Technologies Q2 FY27 Results: Net Loss of ₹30.4 Cr
MosChip Technologies Ltd reported revenue from operations of ₹119.1 Cr (-18.9% YoY) and a net loss of ₹30.4 Cr for Q2 FY27.
- Key figure
- Net loss ₹30.4 Cr
OnMobile Global Q2 FY27 Results: Net Loss of ₹10.5 Cr
OnMobile Global Ltd reported revenue from operations of ₹127.1 Cr (-0.9% YoY) and a net loss of ₹10.5 Cr for Q2 FY27.
- Key figure
- Net loss ₹10.5 Cr
Zensar Technologies Q2 FY27 Results: Net Profit ₹190.2 Cr, Up 4.4% YoY
Zensar Technologies Ltd reported revenue from operations of ₹1,585 Cr (+11.5% YoY) and net profit of ₹190.2 Cr (+4.4% YoY) for Q2 FY27.
- Key figure
- Net profit ₹190.2 Cr · +4.4% YoY
GMR Airports Q2 FY27 Results: Net Profit ₹65.4 Cr, Up 86.3% YoY
GMR Airports Ltd reported revenue from operations of ₹4,095 Cr (+11.6% YoY) and net profit of ₹65.4 Cr (+86.3% YoY) for Q2 FY27.
- Key figure
- Net profit ₹65.4 Cr · +86.3% YoY
Hexaware Technologies Q2 FY27 Results: Net Profit ₹429.4 Cr, Up 16.1% YoY
Hexaware Technologies Ltd reported revenue from operations of ₹3,933 Cr (+12.9% YoY) and net profit of ₹429.4 Cr (+16.1% YoY) for Q2 FY27.
- Key figure
- Net profit ₹429.4 Cr · +16.1% YoY